You have Guest access.
Log In
Volume 1 / 1997 - Volume 7 / 2003
Now merged into Journal of Interventional Cardiac Electrophysiology (1997-2012)
181-185
Classification of Antiarrhythmic Drugs
Michael R. Rosen
186-189
Mechanisms of Antiarrhythmic Drug Actions
Stanley Nattel
190-193
Using Antiarrhythmic Drugs: Administration, Pharmacokinetics, and Compliance
Katherine T. Murray
194-205
Antiarrhythmic Impact of Anti-Ischemic, Anti-Failure and Other Cardiovascular Strategies
Michael J. Reiter
206-211
Proarrhythmia: Classification, Incidence, Risk Factors, Monitoring, Prevention and Management
Augustus O. Grant
212-216
Proarrhythmia Related to Prolongation of Repolarization: Mechanisms, Monitoring, Prevention, and Management
Craig T. January and Jonathan C. Makielski
217-221
Proarrhythmia Related to Sodium Channel Blockade II: Postulated Mechanisms of Brugada Syndrome and Their Possible Involvement in Class IC Drug-Induced Ventricular Arrhythmias During Ischemia
Hanno L. Tan and Arthur A.M. Wilde
222-226
Interactions Between Implantable Devices and Antiarrhythmic Drugs
Arnold Pintér and Paul Dorian
227-232
Adenosine: Use as a Diagnostic and Therapeutic Tool
Jamie Beth Conti and Anne B. Curtis
233-234
IV Amiodarone and Evidence-Based Pharmacologic Therapy During Cardiac Arrest
Jeffrey R. Balser
235-236
Bretylium Tosylate (UDATE—2000)
Ernest L. Fallen
237-239
The Role of Calcium Channel Blockers in Restoration and Maintenance of Sinus Rhythm in Patients with Atrial Fibrillation
Bas A. Schoonderwoerd, Trudeke Van Noord and Harry J.G.M. Crijns
240-242
Esmolol and Other Intravenous Beta-Blockers
William H. Maisel and Peter L. Friedman
243-247
Update on Intravenous Ibutilide
Bruce S. Stambler
248-250
Overview of Lidocaine
David Newman
251-254
Update on the Use of Magnesium as an Antiarrhythmic Drug
Terence John Campbell
255-261
Oral Antiarrhythmic Drugs Used for Arrhythmia Prevention
Bengt Herweg and Jonathan S. Steinberg
262-269
Amiodarone Oral
Denis Roy, Mario Talajic, Stanley Nattel, Marc Dubuc and Bernard Thibault, et al.
270-272
Disopyramide Phosphate
Malcolm M. Kirk and Michael R. Gold
273-277
Dofetilide for Atrial Flutter and Fibrillation
P.E. Bloch Thomsen
278-280
Flecainide Acetate—2000 Update
Rodolphe Ruffy
281-283
Moricizine
Susan Brode and Kelley P. Anderson
284-287
Oral Procainamide
Eric J. Rashba, Paul J. Wang and N.A. Mark Estes III
288-291
Propafenone
Jose A. Joglar and Richard L. Page
292-295
Quinidine in Atrial Fibrillation and Ventricular Tachycardia
Andrew A. Grace and A. John Camm
296-300
Clinical Value of d,l-sotalol: Overview of Recent Trials
Joachim R. Ehrlich and Stefan H. Hohnloser
301-308
Beta-Blockers
Jeffery L. Anderson
309-312
Calcium Channel Blockers
D. George Wyse
313-316
Is Digoxin an Antiarrhythmic Drug?
T. David Gbadebo, Alexander Mazur and Mark E. Anderson
317-320
Drugs for the Prevention and Control of Syncope
Jean T. Barbey
321-327
Investigational Class III Antiarrhythmic Agents
Philip T. Sager
Frequently asked questions General info on journals and books Send us your feedback Impressum Contact us
© Springer, Part of Springer Science+Business Media Privacy, Disclaimer, Terms & Conditions, and Copyright Info